Alise Reicin

Director; Director, Chief Executive Officer · 7 filings · Latest: Jun 20, 2026

Immatics N.V.

Sana Biotechnology, Inc.

Tectonic Therapeutic, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
TECX	Alise Reicin	Director, Chief Executive Officer	Feb 11, 2026	Purchase	$21.10	2,500	$52.8K	127,030	Mar 5 9:30 PM 4/A
TECX	Alise Reicin	Director, Chief Executive Officer	Feb 11, 2026	Purchase	$21.10	2,500	$52.8K	237,547	Feb 12 9:15 PM